Anbio Biotechnology (NNNN) Short-term Investments (2023 - 2025)
Anbio Biotechnology (NNNN) recorded quarterly Short-term Investments of $4.1 million in Q4 2025, down 100.0% quarter-over-quarter from $8080.5 billion in Q2 2025.
Anbio Biotechnology (NNNN) Short-term Investments (2023 - 2025) Analysis & Trends
Anbio Biotechnology's Short-term Investments history runs 2 years deep, the most recent figure standing at $4.1 million for Q4 2025.
- In Q4 2025, Short-term Investments changed N/A year-over-year to $4.1 million; the TTM figure through Dec 2025 stood at $4.1 million (changed N/A YoY), while the FY2025 annual figure was $4.1 million, changed N/A from the prior year.
- Short-term Investments was $4.1 million for Q4 2025 at Anbio Biotechnology, down from $8080.5 billion in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $8080.5 billion in Q2 2025 to a low of $3263.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Anbio Biotechnology | 720.59 Mn | 708.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.13 Mn |
| Jun 30, 2025 | 8,080.50 Bn |
| Dec 31, 2023 | 3,263.00 |